Carolinas Wealth Consulting’s Insmed INSM Stock Holding History

Carolinas Wealth Consulting’s Portfolio INSM Stock Details INSM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-47	Closed	-$2K	–	938
2020 Q3	$2K	Buy	+47	New	+$1.35K	﹤0.01%	705

Other funds holding INSM

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Carolinas Wealth Consulting's INSM Position: Q4 2020 in Review

Carolinas Wealth Consulting sold out of Insmed (INSM) in Q4 2020, closing a stake of 47 shares — an estimated $2K sold.

Carolinas Wealth Consulting first reported a position in INSM in Q3 2020 and held it in 1 quarter. The position peaked at $2K in Q3 2020. 206 funds tracked by Wall St. Rank hold INSM as of Q4 2020.

Carolinas Wealth Consulting reported no remaining Insmed position as of Q4 2020 after selling out during the quarter.
Carolinas Wealth Consulting sold 47 Insmed shares in Q4 2020, an estimated $2K.
Carolinas Wealth Consulting first reported a position in Insmed in Q3 2020 and held it in 1 quarter.
Carolinas Wealth Consulting's Insmed position peaked at $2K in Q3 2020.
206 funds tracked by Wall St. Rank held Insmed as of Q4 2020.

Based on Carolinas Wealth Consulting's 13F filing for Q4 2020, filed 16 Feb 2021.